Company Filing History:
1 out of 832,891 Years Active: 2009
Title: David Alexander - Innovator in Tuberculosis Vaccine Development
Introduction
David Alexander is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medical research, particularly in the development of vaccines for tuberculosis. His innovative work focuses on enhancing the efficacy of vaccines through recombinant technology.
Latest Patents
David Alexander holds a patent for "Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase." This invention relates to a live recombinant-BCG strain that comprises a nucleic acid capable of expression. The nucleic acid encodes at least one protein or polypeptide that exhibits alanine dehydrogenase activity, glutamine synthetase activity, or serine dehydratase activity. He has 1 patent to his name.
Career Highlights
Throughout his career, David has focused on innovative solutions to combat infectious diseases. His work has been instrumental in advancing the understanding and treatment of tuberculosis, a disease that continues to pose a significant public health challenge worldwide.
Collaborations
David has collaborated with several esteemed colleagues in his field, including Jun Liu and Jeffrey Chen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
David Alexander's contributions to tuberculosis vaccine development highlight his commitment to improving public health through innovation. His work exemplifies the impact that dedicated inventors can have on addressing global health challenges.